Cargando…

Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review

Stroke is one of the world's leading causes of disability and death. Antiplatelet agents are administered to acute ischemic stroke patients as secondary prevention. Clopidogrel involves biotransformation by cytochrome P450 (CYP) enzymes into an active metabolite, and single nucleotide polymorph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alhazzani, Adel, Venkatachalapathy, Poongothai, Padhilahouse, Sruthi, Sellappan, Mohan, Munisamy, Murali, Sekaran, Mangaiyarkarasi, Kumar, Amit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222621/ https://www.ncbi.nlm.nih.gov/pubmed/34177775 http://dx.doi.org/10.3389/fneur.2021.667234

Ejemplares similares

Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice
por: Venkatachalapathy, Poongothai, et al.
Publicado: (2021)

Pharmacogenetics of CYP2C19 genetic polymorphism on clopidogrel response in patients with ischemic stroke from Saudi Arabia
por: Alhazzani, Adel A., et al.
Publicado: (2017)

A Case of Failed Dual Antiplatelet Therapy With Oral Anticoagulant in the Prevention of Acute Ischemic Stroke
por: Amoda, Oluyemisi, et al.
Publicado: (2021)

Impact of Diabetes on Platelet Function in Acute Ischemic Stroke Patients Taking Dual Antiplatelet Therapy
por: Guo, Yinping, et al.
Publicado: (2021)

Dual vs. mono antiplatelet therapy for acute ischemic stroke or transient ischemic attack with evidence of large artery atherosclerosis
por: Lin, Chun-Jen, et al.
Publicado: (2022)

Role of troponin as a biomarker for predicting outcome after ischemic stroke
por: Alhazzani, Adel, et al.
Publicado: (2021)

Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review
por: Vališ, Martin, et al.
Publicado: (2021)

Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke
por: Liu, Tingting, et al.
Publicado: (2022)

Editorial: Blood-Based Biomarkers in Acute Ischemic Stroke and Hemorrhagic Stroke
por: Uphaus, Timo, et al.
Publicado: (2022)

Corrigendum: Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke
por: Liu, Tingting, et al.
Publicado: (2022)

Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience
por: Lin, Sheng-Feng, et al.
Publicado: (2021)

Leukocyte Biomarkers for the Differential Diagnosis of Mild Acute Ischemic Stroke, Transient Ischemic Attack, and Stroke Mimic
por: Cavrak, Megan E, et al.
Publicado: (2021)

Corrigendum: Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience
por: Lin, Sheng-Feng, et al.
Publicado: (2021)

Editorial: Antiplatelet Agents in Stroke Prevention
por: Feher, Gergely, et al.
Publicado: (2021)

Protected Stroke Mechanical Thrombectomy Code During the Coronavirus (COVID-19) Pandemic: Southwestern Part of Saudi Arabia Stroke Unit Local Protocol
por: Alqahtani, Saeed A, et al.
Publicado: (2020)

Dual-Antiplatelet Therapy May Not Be Associated With an Increased Risk of In-hospital Bleeding in Patients With Moderate or Severe Ischemic Stroke
por: Khazaal, Ossama, et al.
Publicado: (2021)

High Actin Expression in Thrombus of Acute Ischemic Stroke Can Be a Biomarker of Atherothrombotic Origin Stroke
por: Wang, Rongyu, et al.
Publicado: (2022)

Identification of immune-related biomarkers co-occurring in acute ischemic stroke and acute myocardial infarction
por: Wang, Shan, et al.
Publicado: (2023)

Appropriate use of antiplatelet medications following transient ischemic attacks and stroke: a 9-year study from the Middle East
por: Naveed, Hiba, et al.
Publicado: (2023)

Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease
por: Ye, Fei, et al.
Publicado: (2021)

Neuroimaging biomarkers of cognitive recovery after ischemic stroke
por: Tahmi, Mouna, et al.
Publicado: (2022)

Exosomal microRNAs as Potential Biomarkers and Therapeutic Agents for Acute Ischemic Stroke: New Expectations
por: Xu, Yingzhi, et al.
Publicado: (2022)

S100b in acute ischemic stroke clots is a biomarker for post-thrombectomy intracranial hemorrhages
por: Rossi, Rosanna, et al.
Publicado: (2023)

Association of Anemia with Stroke Severity in Acute Ischemic Stroke Patients
por: Khan, Muhammad F, et al.
Publicado: (2018)

Antiplatelet Use in Ischemic Stroke
por: Kamarova, Marharyta, et al.
Publicado: (2022)

Dual Antiplatelet Therapy in Patients With Minor Stroke Receiving Intravenous Thrombolysis
por: Xu, Zhaohan, et al.
Publicado: (2022)

Machine Learning in Acute Ischemic Stroke Neuroimaging
por: Kamal, Haris, et al.
Publicado: (2018)

In-Silico Trials for Treatment of Acute Ischemic Stroke
por: Konduri, Praneeta R., et al.
Publicado: (2020)

Editorial: Reperfusion Therapy for Acute Ischemic Stroke
por: Mishra, Nishant K., et al.
Publicado: (2019)

Treatment Challenges in Acute Minor Ischemic Stroke
por: Slawski, Diana, et al.
Publicado: (2021)

Editorial: Challenges in Acute Minor Ischemic Stroke
por: Heldner, Mirjam R., et al.
Publicado: (2022)

Magnetic Resonance Imaging in Acute Ischemic Stroke
por: Tedyanto, Eric Hartono, et al.
Publicado: (2022)

Discovery of a New Biomarker Pattern for Differential Diagnosis of Acute Ischemic Stroke Using Targeted Metabolomics
por: Sun, Ruitan, et al.
Publicado: (2019)

Lipid Paradox in Statin-Naïve Acute Ischemic Stroke But Not Hemorrhagic Stroke
por: Cheng, Kai-Hung, et al.
Publicado: (2018)

Expression of Cytokines and Chemokines as Predictors of Stroke Outcomes in Acute Ischemic Stroke
por: Martha, Sarah R., et al.
Publicado: (2020)

Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Stroke Severity and Short-Term Prognosis in Acute Ischemic Stroke With Intracranial Atherosclerotic Stenosis
por: Ying, Yuanlin, et al.
Publicado: (2021)

Clopidogrel Resistance in Patients With Stroke Recurrence Under Single or Dual Antiplatelet Treatment
por: Kang, Hyun Goo, et al.
Publicado: (2021)

Serum Sphingosine 1-Phosphate (S1P): A Novel Diagnostic Biomarker in Early Acute Ischemic Stroke
por: Liu, Jia, et al.
Publicado: (2020)

Bioinformatics Identification of Ferroptosis-Related Biomarkers and Therapeutic Compounds in Ischemic Stroke
por: Chen, Guozhong, et al.
Publicado: (2021)

Blood-Based Biomarkers: A Forgotten Friend of Hyperacute Ischemic Stroke
por: Liu, Zhilan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_406qm1dn5ttngf0jddaarttvh5